Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.69M

combined est. value

Stock	Shares	Price	Value	Weight	As of
CGEMCullinan Therapeutics, Inc.	174,844	$15.36	$2.69M	100%	2026-02-25

CGEM

Cullinan Therapeutics, Inc.

$2.69M

174,844 sh

All filings on record

Every Form 4 transaction we track for this filer

all 14buys 0sells 12

Stock	Transaction	Date	~6mo later
CGEMCullinan Therapeutics, Inc.	Sell $25.2K · 1,780 sh	2026-02-25	—
CGEMCullinan Therapeutics, Inc.	Sell $52.1K · 3,601 sh	2026-02-24	—
CGEMCullinan Therapeutics, Inc.	Sell $24.5K · 1,752 sh	2026-02-23	—
CGEMCullinan Therapeutics, Inc.	Sell $114.4K · 8,000 sh	2026-02-20	—
CGEMCullinan Therapeutics, Inc.	Exercise $34.4K · 8,000 sh	2026-02-20	—
CGEMCullinan Therapeutics, Inc.	Sell $51.0K · 3,742 sh	2026-02-20	—
CGEMCullinan Therapeutics, Inc.	Grant — · 57,500 sh	2026-02-18	—
CGEMCullinan Therapeutics, Inc.	Sell $5.0K · 416 sh	2026-02-12	—
CGEMCullinan Therapeutics, Inc.	Sell $49.2K · 4,000 sh	2026-01-22	—
CGEMCullinan Therapeutics, Inc.	Sell $13.5K · 1,345 sh	2025-12-19	—
CGEMCullinan Therapeutics, Inc.	Sell $28.0K · 2,898 sh	2025-12-18	—
CGEMCullinan Therapeutics, Inc.	Sell $11.8K · 995 sh	2025-12-15	—
CGEMCullinan Therapeutics, Inc.	Sell $26.6K · 2,148 sh	2025-12-12	—
CGEMCullinan Therapeutics, Inc.	Sell $49.2K · 4,000 sh	2025-11-24	—

CGEMSell

2026-02-25 · Cullinan Therapeutics, Inc.

$25.2K

—

CGEMSell

2026-02-24 · Cullinan Therapeutics, Inc.

$52.1K

—

CGEMSell

2026-02-23 · Cullinan Therapeutics, Inc.

$24.5K

—

CGEMSell

2026-02-20 · Cullinan Therapeutics, Inc.

$114.4K

—

CGEMExercise

2026-02-20 · Cullinan Therapeutics, Inc.

$34.4K

—

CGEMSell

2026-02-20 · Cullinan Therapeutics, Inc.

$51.0K

—

CGEMGrant

2026-02-18 · Cullinan Therapeutics, Inc.

57,500

—

CGEMSell

2026-02-12 · Cullinan Therapeutics, Inc.

$5.0K

—

CGEMSell

2026-01-22 · Cullinan Therapeutics, Inc.

$49.2K

—

CGEMSell

2025-12-19 · Cullinan Therapeutics, Inc.

$13.5K

—

CGEMSell

2025-12-18 · Cullinan Therapeutics, Inc.

$28.0K

—

CGEMSell

2025-12-15 · Cullinan Therapeutics, Inc.

$11.8K

—

CGEMSell

2025-12-12 · Cullinan Therapeutics, Inc.

$26.6K

—

CGEMSell

2025-11-24 · Cullinan Therapeutics, Inc.

$49.2K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.